E78.5
Hyperlipidemia, unspecified
Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 9 more
specific codes sit alongside it. Worth
checking whether the documentation supports one of them.
Exclusions 8 never code together
E78code
Excludes1
- sphingolipidosis (E75.0-E75.3)E75.0-E75.3
E70-E88block
E00-E89chapter
Excludes1
- transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes 1
E00-E89chapter
Notes
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here 5
Alongside this code 9 same parent — E78
E78.0 Pure hypercholesterolemia category E78.1 Pure hyperglyceridemia E78.2 Mixed hyperlipidemia E78.3 Hyperchylomicronemia E78.4 Other hyperlipidemia category E78.6 Lipoprotein deficiency E78.7 Disorders of bile acid and cholesterol metabolism category E78.8 Other disorders of lipoprotein metabolism category E78.9 Disorder of lipoprotein metabolism, unspecified
Medications 1
MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.
Additional references
AHA Coding Clinic® Licence required
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.